KHK2823 is a humanized monoclonal antibody targeting human CD123/IL3RA. The recommended isotype control for this compound is human IgG1 kappa, serving as an isotype control. KHK2823 is applicable in leukemia-related research.
Target:
Interleukin
* VAT and and shipping costs not included. Errors and price changes excepted